LUYE PHARMA GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.960 HKD | +0.34% |
|
0.00% | -20.64% |
| 08-30 | Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4 | MT |
| 08-28 | Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
EPS & Dividend: Luye Pharma Group Ltd.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.113 | - | - | - | - | - | - | - |
| Rate of return | 2.16% | - | - | - | - | - | - | - |
| EPS 2 | 0.4584 | 0.2212 | -0.039 | 0.1738 | 0.1429 | 0.212 | 0.2461 | 0.3037 |
| Distribution rate | 24.7% | - | - | - | - | - | - | - |
| Reference price 2 | 5.221 | 3.040 | 2.900 | 3.237 | 3.386 | 2.695 | 2.695 | 2.695 |
| Nbr of stocks (in thousands) | 3,268,965 | 3,248,965 | 3,541,372 | 3,549,671 | 3,761,671 | 3,761,671 | - | - |
| Announcement Date | 26/03/20 | 31/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: Luye Pharma Group Ltd.
| 28/06/2020 | Final Payment 0.06 HKD |
| 08/09/2019 | Interim Payment 0.067 HKD |
| 13/06/2019 | Final Payment 0.065 HKD |
| 05/09/2018 | Interim Payment 0.051 HKD |
| 13/06/2018 | Final Payment 0.054 HKD |
| 03/10/2017 | Interim Payment 0.033 HKD |
| 14/06/2017 | Final Payment 0.039 HKD |
| 03/10/2016 | Interim Payment 0.037 HKD |
Upcoming events: Luye Pharma Group Ltd.
| 25/03/2025 | Q4 2024 Earnings Release (Projected) |
| 26/08/2025 | Q2 2025 Earnings Release (Projected) |
| 31/03/2026 | Q4 2025 Earnings Release (Projected) |
| 01/09/2026 | Q2 2026 Earnings Release (Projected) |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 12.71x | 0.7244 | 1.85x | ||
| +0.57% | +0.66% | 58.43x | 40.26 | 18.1x | ||
| +1.26% | +1.66% | 39.78x | 27.88 | 13.85x | ||
| +2.80% | +3.07% | 21.39x | 5.693 | 4.63x | ||
| +3.22% | +3.33% | 37.65x | 40.89 | 7.14x | ||
| +2.60% | +2.73% | 15.77x | 6.109 | 5.01x | ||
| +3.70% | +3.79% | 15.97x | 5.832 | 3.78x | ||
| +1.97% | +2.07% | 28.23x | 5.807 | 5.08x | ||
| +3.27% | +3.39% | 21.48x | 5.252 | 4.95x | ||
| +2.76% | +2.98% | 51.27x | 35.64 | 6.9x | ||
| Average | +2.21% | +2.37% | 30.27x | 17.41 | 7.13x | |
| Weighted average by Cap. | +2.05% | +2.23% | 36.45x | 23.18 | 9.93x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition